Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973–2012)

References

• JovanovicPMihajlovicMDjordjevic-JocicJVlajkovicSCekicSStefanovicVOcular melanoma: an overview of the current statusInt J Clin Exp Pathol201361230124423826405
   PubMed Web of Science ®Google Scholar
• McLaughlinCCWuXCJemalAMartinHJRocheLMChenVWIncidence of noncutaneous melanomas in the U.SCancer20051031000100715651058
   PubMed Web of Science ®Google Scholar
• IsagerPOsterlindAEngholmGUveal and conjunctival malignant melanoma in Denmark, 1943–1997: incidence and validation studyOphthalmic Epidemiol20051222323216033743
   PubMed Web of Science ®Google Scholar
• SinghADTurellMETophamAKUveal melanoma: trends in incidence, treatment, and survivalOphthalmology20111181881188521704381
   PubMed Web of Science ®Google Scholar
• NicholsEERichmondADanielsABDisparities in uveal melanoma: patient characteristicsSemin Ophthalmol20163129630327128153
   PubMed Web of Science ®Google Scholar
• EskelinSKivelaTMode of presentation and time to treatment of uveal melanoma in FinlandBr J Ophthalmol20028633333811864894
   PubMed Web of Science ®Google Scholar
• DamatoEMDamatoBEDetection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patientsOphthalmology20121191582158922503229
   PubMed Web of Science ®Google Scholar
• Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1Arch Ophthalmol1990108126812732205183
   PubMedGoogle Scholar
• PereiraPROdashiroANLimLACurrent and emerging treatment options for uveal melanomaClin Ophthalmol201371669168224003303
   PubMedGoogle Scholar
• IsagerPEngholmGOvergaardJStormHUveal and conjunctival malignant melanoma in Denmark 1943–1997: observed and relative survival of patients followed through 2002Ophthalmic Epidemiol200613859616581612
   PubMed Web of Science ®Google Scholar
• BlumESYangJKomatsubaraKMCarvajalRDClinical management of uveal and conjunctival melanomaOncology (Williston Park)201630293234434826791842
   PubMed Web of Science ®Google Scholar
• SinghADTurellMETophamAKUveal melanoma: trends in incidence, treatment, and survivalOphthalmology20111181881188521704381
   PubMed Web of Science ®Google Scholar
• ParidaensADMcCartneyACHungerfordJLMultifocal amelanotic conjunctival melanoma and acquired melanosis sine pigmentoBr J Ophthalmol1992761631651540561
   PubMed Web of Science ®Google Scholar
• MissottenGSKeijserSDe KeizerRJDe Wolff-RouendaalDConjunctival melanoma in the Netherlands: a nationwide studyInvest Ophthalmol Vis Sci200546758215623757
   PubMed Web of Science ®Google Scholar
• EsmaeliBWangXYoussefAGershenwaldJEPatterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decadesOphthalmology20011082101210511713086
   PubMed Web of Science ®Google Scholar
• SeregardSConjunctival melanomaSurv Ophthalmol1998423213509493274
   PubMed Web of Science ®Google Scholar
• ChangAEKarnellLHMenckHRThe National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer SocietyCancer199883166416789781962
   PubMed Web of Science ®Google Scholar
• YuGPHuDNMcCormickSFingerPTConjunctival melanoma: is it increasing in the United States?Am J Ophthalmol200313580080612788119
   PubMed Web of Science ®Google Scholar
• TuomaalaSEskelinSTarkkanenAKivelaTPopulation-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whitesInvest Ophthalmol Vis Sci2002433399340812407149
   PubMed Web of Science ®Google Scholar
• GraellXCaminalJMMasuetCAge distribution of uveal melanoma and its relationship to survivalArch Soc Esp Oftalmol20078234334717573643
   PubMedGoogle Scholar
• AnastassiouGHeiligenhausABechrakisNBaderEBornfeldNSteuhlKPPrognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective studyBr J Ophthalmol20028616316711815341
   PubMed Web of Science ®Google Scholar
• KimuraKUsuiYGotoHClinical findings and prognosis of 11 cases of conjunctival malignant melanomaNippon Ganka Gakkai Zasshi201211650350922690541
   PubMedGoogle Scholar
• HuDNYuGMcCormickSAFingerPTPopulation-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomasAm J Ophthalmol200814541842318191091
   PubMed Web of Science ®Google Scholar
• MargoCEThe Collaborative Ocular Melanoma Study: an overviewCancer Control20041130430915377989
   PubMedGoogle Scholar
• ShieldsCLConjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patientsTrans Am Ophthalmol Soc20009847149211190037
   PubMedGoogle Scholar
• LimLAMadiganMCConwayRMConjunctival melanoma: a review of conceptual and treatment advancesClin Ophthalmol2013652153123515569
   PubMedGoogle Scholar
• Diener-WestMEarleJDFineSLThe COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18Arch Ophthalmol200111996998211448319
   PubMedGoogle Scholar
• SinghADShieldsCLShieldsJAPrognostic factors in uveal melanomaMelanoma Res20011125526311468514
   PubMed Web of Science ®Google Scholar
• AbramsMJGagneNLMelhusCSMignanoJEBrachytherapy vs. external beam radiotherapy for choroidal melanoma: survival and patterns-of-care analysesBrachytherapy20161521622326846381
   PubMed Web of Science ®Google Scholar
• The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10Am J Ophthalmol19981257797969645716
   PubMed Web of Science ®Google Scholar
• Diener-WestMHawkinsBSMarkowitzJASchachatAPA review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988Arch Ophthalmol19921102452501531290
   PubMed Web of Science ®Google Scholar
• KrollSCharDHQuiveyJCastroJA comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanomaOphthalmology1998105203520459818602
   PubMed Web of Science ®Google Scholar
• SeddonJMGragoudasESEganKMRelative survival rates after alternative therapies for uveal melanomaOphthalmology1990977697772374681
   PubMed Web of Science ®Google Scholar
• SeregardSLong-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patientsActa Ophthalmol Scand19997741441710463412
   PubMedGoogle Scholar
• OosterhuisJAJournee-de KorverHGKakebeeke-KemmeHMBleekerJCTranspupillary thermotherapy in choroidal melanomasArch Ophthalmol19951133153217887845
   PubMedGoogle Scholar
• Journee-de KrverHSchalij-DelfosNImhofSUveal malignant melanoma: management options – thermotherapySinghADamatoBPe’erJClinical Ophthalmic OncologyPhiladelphia, PASaunders Elsevier2007232240
   Google Scholar
• ShieldsCLShieldsJAPerezNSinghADCaterJPrimary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitationsOphthalmology200210922523411825800
   PubMed Web of Science ®Google Scholar
• RobertsonDMBuettnerHBennettSRTranspupillary thermotherapy as primary treatment for small choroidal melanomasArch Ophthalmol19991171512151910565520
   PubMedGoogle Scholar
• HarbourJWChaoDLA molecular revolution in uveal melanoma: implications for patient care and targeted therapyOphthalmology20141211281128824480708
   PubMed Web of Science ®Google Scholar
• MoserJCPulidoJSDroncaRSMcWilliamsRRMarkovicSNMansfieldASThe Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanomaMelanoma Res201525596325396683
   PubMed Web of Science ®Google Scholar
• TriozziPDacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance ClinicalTrials.gov. Identifier: NCT011005282016
   Google Scholar
• WenXLuLHeZFanXOrchestrating epigenetic roles targeting ocular tumorsOnco Targets Ther201691001100927013893
   PubMed Web of Science ®Google Scholar
• VenzaMVisalliMBeninatiCBiondoCTetiDVenzaIRole of genetics and epigenetics in mucosal, uveal, and cutaneous melanomagenesisAnticancer Agents Med Chem201616552853826234362
   PubMed Web of Science ®Google Scholar
• RajaiiFAsnaghiLEnkeRMerbsSLHandaJTEberhartCGThe demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanomaInvest Ophthalmol Vis Sci2014556178618625146981
   PubMed Web of Science ®Google Scholar
• DaiWZhouJJinBPanJClass III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanomaSci Rep201662262226940009
   PubMed Web of Science ®Google Scholar